ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Renvela® Filmtabletten:Sanofi-Aventis (Suisse) SA
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
V03AE02 - SevelamerATC-DDD Version 2016. Source: WHO
V - Various
 

This group comprises many different types of drugs, and assigning DDDs are difficult. Very few DDDs are assigned in this group.

V03 - All Other Therapeutic Products
 
V03A - All Other Therapeutic Products
 
V03AE - Drugs for Treatment Of Hyperkalemia and Hyperphosphatemia

Plain calcium products also used in hyperphosphatemia are classified in A12AA.

The DDD for lanthanum carbonate is expressed as lanthanum and is equivalent to 4.3 g lanthanum carbonate.
The DDD for ferric citrate is based on the recommended dose for chronic kidney disease patients not on dialysis.
The DDD for patiromer calcium is based on the recommended starting dose.

V03AE02 - Sevelamer
DoseRoute of administrationNote
 O 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home